Combined Motor and Cognitive Training for Older Adults With Motoric Cognitive Risk Syndrome (CMC-training)
Launched by XUANWU HOSPITAL, BEIJING · Aug 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called CMC-training, is looking at how a special program that combines physical exercise and mental activities can help improve both movement and thinking skills in older adults who may have some cognitive difficulties. The goal is to see if this combined approach can make a positive difference in the lives of community-dwelling seniors, particularly those who may be experiencing slow walking and mild cognitive impairment.
To be eligible for this study, participants should be between 60 and 80 years old, have completed at least 9 years of education, and have mild cognitive issues as indicated by a specific memory test score. They should also walk slowly but not too slowly, as measured in a short walking test. However, individuals with dementia, certain medical conditions that affect thinking, or those who have recently had serious health issues will not be able to participate. If someone joins the study, they can expect to take part in exercises and activities designed to boost both their physical and mental abilities while being monitored by the research team. This study is currently recruiting participants who meet the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 60-80 years; ≥ 9 years of education; Cognitive impairment: MMSE score 22-26; Slow gait:total walking time \>4 seconds and ≤8 seconds in a 4-meter walk test; Agreed to participate in the study and signed an informed consent form.
- Exclusion Criteria:
- • Dementia/suspected dementia; Suffering from diseases that affect cognitive function, such as cerebrovascular disease, Parkinson's syndrome, etc.; Taking medications related to cognitive improvement and psychiatric disorders, etc.; Recent heart attack, severe cerebrovascular disease, psychiatric disorders, etc.; other inability to persist in completing exercise cognitive interventions, such as suffering from severe musculoskeletal disorders; Participating in another clinical trial at the same time; Participation in an exercise and/or cognitive intervention in the past 6 months; Inability to complete content in studies such as neuropsychological scale assessments.
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Yi Tang, MD., PhD.
Principal Investigator
Xuanwu Hospital, Beijing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported